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EVIDENCE-BASED DIAGNOSTICS
Systematic Review and Meta-analysis of
Pregnant Patients Investigated for Suspected
Pulmonary Embolism in the Emergency
Department
Jeffrey A. Kline, MD, Danielle M. Richardson, Martin P. Than, MBBS, Andrea Penaloza, MD, PhD, and
Pierre-Marie Roy, MD
Abstract
Objectives: Pregnancy causes a small increase in risk of venous thromboembolism (VTE), but a large
increase in concern upon presentation to an emergency department (ED) with symptoms of pulmonary
embolism (PE), which may cause physicians to employ a low test threshold. This was a systematic review
with the hypothesis that symptomatic pregnant patients in the ED have a low relative risk (RR) for VTE
outcome.
Methods: Studies in all languages were identiﬁed by structured search of PubMed, EMBASE, the
Cochrane library, and bibliographies in February 2014. Papers with ED patients evaluated for possible
PE that included pregnancy status, and had adequate reference standards, were included. An outcome of
VTE (either deep venous thrombosis [DVT] or PE) was considered disease-positive (VTE+). Papers were
assessed for selection and publication bias, and heterogeneity (I2). The random effects model was used if
I2 > 24%.
Results: Seventeen full-length studies of 25,339 patients were analyzed. Pooled data showed I² = 0% with
a symmetrical funnel plot. Two small studies with less than 1% of all patients had evidence of selection
bias. The frequency of VTE+ rate among the 506 pregnant patients was 4.1% (95% conﬁdence interval
[CI] = 2.6% to 6.0%), compared with 12.4% (95% CI = 9.0% to 16.3%) among nonpregnant patients. The
pooled RR of pregnancy for VTE+ diagnosis was 0.60 (95% CI = 0.41 to 0.87). Patients in the third
trimester had a RR of 0.85 (95% CI = 0.40 to 1.77), and patients of childbearing age (≤45 years) had a RR
of 0.56 (95% CI = 0.34 to 0.93).
Conclusions: In the ED setting, physicians test for PE in pregnant patients at a low threshold, resulting
in a low rate of VTE diagnosis and a RR of VTE that is lower than that for nonpregnant women of
childbearing age who are tested for PE in the ED setting.
ACADEMIC EMERGENCY MEDICINE 2014;21:949–959 © 2014 by the Society for Academic Emergency
Medicine
A pregnant woman who presents to an emer-gency department (ED) with signs or symptomsof possible pulmonary embolism (PE) poses a
difﬁcult diagnostic challenge for the clinician, who must
balance the need to avoid radiation and contrast expo-
sure to the mother and fetus, against the specter of
missing a PE diagnosis that, left untreated, could cause
harm to two patients simultaneously.1 Decision-making
is complicated by the fact that pregnancy increases risk
of clotting and causes physiologic changes that to some
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extent mimic those of PE, including dyspnea, leg swell-
ing, and an increased resting heart rate. Pregnancy also
increases the plasma D-dimer level, thus complicating
its use as a rule-out test.2–4 The inﬂuences of traditional
medical teaching and the practice of grouping the risk
of deep venous thrombosis (DVT) and PE together for
pregnant patients, added to the emotional consequences
of missing PE in pregnancy, may prompt clinicians to
initiate the diagnostic process for PE in pregnant
patients at an exceedingly low test threshold. Indeed,
pregnancy is absent as a criterion in all structured clini-
cal decision rules for PE.5,6
Clinicians may perceive that pregnant patients have a
high risk of PE because epidemiologic data show that
pregnancy and the postpartum state increase a
woman’s risk of venous thromboembolism (VTE),
including PE and DVT. However, if these data are ana-
lyzed by removing women who were postpartum, or
who had isolated DVT, then the absolute risk for PE in
pregnancy is relatively small. In Olmsted County, Min-
nesota, Heit et al.7,8 found the rate of diagnosed PE in
pregnant patients was 32/100,000, which is about the
same as for all women under 40 years of age in the
same region. In the United Kingdom, Sultan et al.9,10
found the overall rate of VTE (including both DVT and
PE) was 20/100,000 person-years among women of
childbearing age, compared with 55/100,000 person-
years for pregnant women with one risk factor for VTE.
In contrast, Sultan et al. reported that the rate of VTE
was 421/100,000 person-years in the early postpartum
period.9 In a meta-analysis of 23 epidemiologic studies,
Meng et al.11 found that 70% of all PEs diagnosed dur-
ing the entire course of pregnancy and delivery
occurred postpartum and that PE occurs in only three
out of 10,000 pregnancies. Thus, we hypothesize that
emergency physicians may overestimate the risk of VTE
in pregnant patients with symptoms of PE and therefore
order diagnostic testing liberally, resulting in a low out-
come rate of VTE.
To test this hypothesis, we aimed to measure the out-
come rate, or prevalence, of VTE among ambulatory
pregnant patients tested for PE and to compare this
prevalence to the VTE rate among nonpregnant
patients. To accomplish this we conducted a systematic
literature review and meta-analysis to quantify the rate
of diagnosis and relative risk (RR) for VTE among
symptomatic pregnant patients tested for PE.
METHODS
The main question of this work was to determine the
pooled prevalence of VTE in symptomatic pregnant ED
patients for whom clinicians order a diagnostic test for
PE, to inform discussion about the test threshold that
clinicians are currently using to order a diagnostic test
for pregnant patients with symptoms of PE. The test
threshold represents the lowest pretest probability at
which clinicians decide to order a diagnostic test.12
For PE, it has been well established that pretest proba-
bility is arithmetically linked to the posttest probability
using the likelihood ratio for the diagnostic strategy.6
Therefore, assuming the inclusion of studies that
employed reference standards that produce narrow
likelihood ratio negative ranges, the rate of positive
VTE diagnosis (VTE+) and the RR of pregnancy will
reﬂect the test threshold. The methodology used fol-
lows that recommended by the MOOSE standardized
reporting guidelines.13
Literature Search
In February 2014, we performed a systematic search of
MEDLINE, the Cochrane library, and EMBASE for
studies that examined ED samples of patients evaluated
for suspected PE that did not exclude pregnant patients.
The methods were registered at http://www.crd.york.ac.
uk/PROSPERO/. We ﬁrst established a search strategy
likely to ﬁnd relevant studies of PE diagnosis. We used
sequential search strategies in MEDLINE using PubMed
designed to capture studies of diagnosis, diagnostic
accuracy, and outcomes. We used the following inde-
pendent search strategies, abbreviated here for clarity:
PE and: Emergency; Diagnosis; Diagnostic accuracy;
Outcomes; Pregnancy; D-dimer. With assistance from a
medical librarian, we searched EMBASE using three
concept groups: PE, emergency medicine, and risk/
accuracy/predictive value/incidence, while precluding
entry of duplicate citations. The details of these search
strategies are shown in Data Supplement S1 (available
as supporting information in the online version of this
paper).
Other sources included a search of the Cochrane
library database using the term *embolism. We also
searched the bibliographies of meta-analyses and book
chapters on topics relevant to PE diagnosis: clinical
decision rules,6,14,15 D-dimer,16,17 clinical pathways and
guidelines,18–21 and other diagnostic methods.22–24 In
addition, we queried www.clinicaltrials.gov for studies
involving pregnancy and e-mailed known researchers in
the ﬁeld to ﬁnd so-called gray-zone or fugitive literature.
Two authors (DMR and JAK) reviewed the results of
the search for relevance and independently read the
titles and abstracts of all retrieved citations. The inclu-
sion criteria were: studies of symptomatic ED patients
who underwent objective diagnostic testing for PE
which included data on risk factors for VTE. We
assessed interobserver reliability with Cohen’s kappa.
The same two authors independently read the retained
full-length articles for the following criteria: evidence of
inclusion of women of childbearing age and the possi-
bility that pregnancy status may have been collected
and evidence of a prospective or retrospective diagnos-
tic algorithm with a predeﬁned reference standard for
PE that included at least either pulmonary vascular
imaging or mixed-objective testing, plus clinical out-
comes assessed >30 days after evaluation. Exclusion cri-
teria included the written statement that pregnant
patients were excluded; those studies that clearly indi-
cated the data were nonadditive (i.e., redundant with
previously published data) and including secondary
analyses of other published data. Discordances were
resolved by consensus with a third author (MT) as arbi-
trator. For papers that reported outcomes of DVT and
PE separately, we report the outcome of either diagno-
sis (VTE) within 90 days. To calculate the RR, each study
had to report the rate of VTE diagnosis among those
patients who were pregnant and among those who
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were not. We also recorded the outcomes of patients
with third-trimester status when these data were avail-
able. When necessary, we e-mailed the corresponding
authors for these data up to three times. Studies that
did not include pregnancy data and had no author clari-
ﬁcation were excluded.
We graded study quality using the Quality Assess-
ment of Diagnostic Accuracy Studies tool (QUADAS-2),
using a standard form.25 Because we were studying the
RR of a clinical feature, as opposed to the diagnostic
accuracy of a test, we did not consider domain 2 (index
testing) of QUADAS as relevant. Each study was graded
as “low risk,” “high risk,” or “unclear risk” for bias in
terms of selection of patients and reference standard.
For patient selection, we considered a study low risk if
it enrolled patients under conditions similar to what an
emergency physician is likely to experience in evaluat-
ing a symptomatic patient in the ED without preselec-
tion by a physician, a diagnostic test, or clinical
selection criteria. We considered patient selection bias
at high risk if the paper or personal communication
with the author indicated that any of these preselection
criteria were applied prior to data collection. We con-
sidered the reference standard at low risk of bias if all
patients had either pulmonary vascular imaging or D-
dimer test and clinical follow-up at >45 days that was
free of VTE. Studies without these criteria had high-risk
reference standards. Studies lacking sufﬁcient criteria to
understand patient selection or reference standard had
unclear risk. The reference standard for VTE– status
required use of a test known to produce a likelihood
ratio negative less than 0.20, including one of the fol-
lowing: negative quantitative D-dimer result together
with negative clinical follow-up performed >30 days
after enrollment, diagnostic negative scintillation lung
scan result interpreted according to well-accepted crite-
ria, or negative computerized tomographic pulmonary
artery (CTPA) scanning.16,20,26 We considered diagnosis
of VTE+ to include either PE or DVT because most stud-
ies of diagnostic accuracy consider a diagnosis of DVT
made in a patient with symptoms of PE as tantamount
to a diagnosis of PE.20 The reference standard for VTE+
diagnosis required any of the following incident within
90 days of enrollment: diagnostic high-probability venti-
lation perfusion lung scanning, positive CTPA scan,
positive formal pulmonary angiography, positive
autopsy for PE, or DVT conﬁrmed with compression
ultrasonography or magnetic resonance imaging.
Data Analysis
For included studies, we generated a table of total num-
ber of nonpregnant patients (females and males), the
number that were VTE+, and total number with preg-
nancy-related VTE. We also recorded the same data for
postpartum status. The primary comparison was the RR
for VTE+ among pregnant patients by comparing the
proportions of VTE+ pregnant patients to nonpregnant
patients. We assessed for heterogeneity between studies
using Cochran’s Q-test (p < 0.05) or the inconsistency
index (I2). We screened for publication bias using the
test of Egger for asymmetry of the funnel plot.27 We
report the RR from the random-effects model and the
ﬁxed-effects RR only if heterogeneity was low
(I2 < 25%).28 Unless otherwise stated, all reported conﬁ-
dence intervals (CIs) are from the random effects model.
We performed two sensitivity analyses: we removed
studies with selection bias, and we compared studies
drawn from American versus populations from other
countries, because prior work found a signiﬁcantly
lower rate of VTE diagnosis in American ambulatory
populations with suspected PE than is found in Euro-
pean countries.29 We tested the effect of trimester and
age on RR in two subgroup analyses: the RR the third
trimester of pregnancy and the VTE+ rate and the RR
for pregnant patients compared with nonpregnant
patients of childbearing age (age ≤ 45 years).7,8
RESULTS
The search revealed 2,816 titles and abstracts that were
screened for relevance by two independent reviewers,
yielding a good combined interobserver reliability for
retained studies (j = 0.80; 95% CI = 0.77 to 0.83).
Figure 1 shows the selection process and Data Supple-
ment S2 (available as supporting information in the
online version of this paper) shows the breakdown of
results by each search term. Of 178 full-length papers
and 17 abstracts that were retained for review by two
authors, 161 were excluded for the reasons in Data
Supplement S2, leaving 17 full-length papers and two
abstracts for data abstraction. To obtain additional
information, we e-mailed 56 authors which returned
error messages in nine cases, no response from 21, and
deﬁnitive responses from 26 (46%). Authors replied that
pregnant patients were excluded (n = 3) or that no preg-
nant patients were enrolled or additional pregnancy
data were not recorded (n = 20) or provided additional
data on outcomes of pregnant patients already
mentioned in the tables of published reports (n = 3).30–33
One author also informed us that an additional case-
control study that included pregnant patients evaluated
for PE was in peer review, and www.clinicaltrials.gov
revealed one clinical trial (NCT00771303) relevant to the
subject matter. Two authors (JAK and MPT) provided
supplemental data from 11 publications using their own
databases.5,34–43
Two readers had perfect agreement on their choices
of 17 retained full-length papers and two abstracts
(Table 1). All 17 full-length papers studied unselected
emergency patients with suspected PE, including non-
pregnant and pregnant patients, whereas both abstracts
included only pregnant patients, and their results are
included in the sensitivity analysis.44,45
Assessment for Bias
Table 1 describes the relevant domains of each study
that might affect bias, including the setting, patient
selection process, and reference standard. All studies
had adequate reference standards, but two studies were
deemed high risk for selection bias from prescreening
with risk stratiﬁcation or diagnostic testing. These two
studies combined represented only 1% of the total num-
ber of patients. We note that no studies explicitly stated
an enrollment requirement for pregnancy testing but all
authors contacted indicated that pregnancy testing was
mandated prior to pulmonary vascular imaging at their
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centers. For the main study question (RR of pregnancy),
pooled data showed minimal heterogeneity [Cochran Q
12.2 (df = 15) p = 0.65; I² = 0% (95% CI = 0 to 46)] and a
relatively symmetrical funnel plot (Egger intercept =
–0.25; 95% CI = –1.5 to 1.0; p = 0.66; Figure 2). Eleven
studies comprising 14,782 (or 58%) of the patients came
from studies on which an author of this work was a pri-
mary author and we conﬁrm that each of these repre-
sented unique patients with no duplication.
Frequency of Evaluation of Pregnant Patients
Table 2 summarizes the number of patients based on
pregnancy and VTE status for each included study. The
17 full-length studies included 25,339 subjects evaluated
for PE in the ED, including 2,636 who had VTE (13%,
95% CI = 10% to 17%). A total of 506 patients were
pregnant, representing 2.0% of all patients (95%
CI = 1.5% to 2.6%, range = 0.7 to 4.6). All 506 pregnant
patients underwent pulmonary vascular imaging.
RR of VTE+ Outcome in Pregnant Patients With
Suspected PE
The forest plot in Figure 3 shows the main study ques-
tion, namely the RR of pregnancy on VTE+ diagnosis in
symptomatic ED patients evaluated for PE. The random-
effects model found the RR was 0.60 (95% CI = 0.41 to
0.87, I² = 0%), and the ﬁxed-effects RR was 0.45 (95%
CI = 0.30 to 0.68).
The frequency of VTE+ diagnosis among 24,833 non-
pregnant patients was 12.4% (95% CI = 9.0% to 16.3%,
I² = 0%), and the frequency of VTE+ diagnosis among
the 506 pregnant patients was 4.1% (95% CI = 2.6% to
6.0%, I² = 0%). The forest plots of these data are shown
in Figure 4.
Sensitivity Analyses. 1) Exclusion of the two small
studies with evidence of selection bias produced a prev-
alence of VTE in nonpregnant patients of 10% (95%
CI = 6% to 15%), a prevalence of VTE in pregnant
patients of 3.7% (95% CI = 2.1% to 5.7%), and a pooled
RR of 0.50 (95% CI = 0.32 to 0.78; I² = 0%). 2) Twelve
studies with patient samples taken only from the ultra-
sound included 18,572 patients, which had a pooled
proportion of pregnant patients of 2.1% (95% CI = 1.5%
to 2.8%; I² = 84%), a pooled rate of VTE+ diagnosis of
3.5% (95% CI = 2.0% to 5.5%; I² = 0%), and a pooled
random effects RR of 0.50 (0.30 to 0.83; I² = 0%).5,30,31,34–
39,43,46,47 3) The ﬁve non-US full-length studies included
6,767 patients with a pooled proportion of pregnant
patients of 1.5% (95% CI = 0.9% to 2.3%; I² = 70%), a
pooled rate of VTE+ diagnosis of 8.2% (95% CI = 1.5%
to 29.7%; I² = 97%), and a pooled random-effects RR
of 0.61 (95% CI = 0.27 to 1.39; I² = 57%).40–42,48,49 4)
Inclusion of the two abstracts of exclusively pregnant
patients (n = 239), which were both performed in
Europe in the nonultrasound analysis, resulted in a RR
of 0.36 (95% CI = 0.13 to 0.99).44,45
Subgroup Analyses. 1) Authors had access to original
data for six studies to calculate the RR speciﬁc to the
third trimester of pregnancy.5,34,36,38,40,49 These six
studies together included 117 (47%) patients in the third
Figure 1. Flow diagram of included studies.
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trimester, of whom four (3.4%, 95% CI = 1% to 7.5%)
were VTE+, and 13,458 nonpregnant patients, of whom
1,118 (8.3%, 95% CI = 7.5% to 15.5%) were VTE+. From
this sample, the RR of third-trimester pregnancy was
0.85 (95% CI = 0.40 to 1.77, random effects). 2) Authors
had access to original data for 11 studies to calculate
the VTE+ rate and RR speciﬁc to patients of childbear-
ing age.5,34–43 This included 8,130 nonpregnant patients
aged ≤ 45 years, of whom 491 were VTE+ (6.2%, 95%
CI = 3.9% to 9.0%), compared with 413 pregnant
patients (age range 18 to 45 years), of whom 13 were
VTE+ (3.7%, 95% CI = 2.1% to 5.7%), resulting in
I² = 0% (95% CI = 0% to 54.4%), a random-effects RR of
0.67 (95% CI = 0.41 to 1.11), and a ﬁxed-effects RR of
0.56 (0.34 to 0.93).
DISCUSSION
This systematic literature review and meta-analysis of
25,339 patients found that among symptomatic ED
patients selected for testing for PE, approximately 2%
were pregnant, and when compared with nonpregnant
patients, the pregnant patients had a RR for VTE+ out-
come of 0.60, signiﬁcantly less than 1 (95% CI = 0.41 to
0.87, random effects). The rate of VTE+ diagnosis from
24,839 nonpregnant patients was 12.4% compared with
a lower rate of VTE+ diagnosis in pregnant patients of
4.1% (95% CI = 2.6 to 6.0). The outcome rate of VTE+ in
pregnant patients was within the 3% to 5% range for
VTE+ outcome that can be expected for patients with a
low pretest probability from a validated clinical decision
rule.6 We believe that these ﬁndings challenge the com-
mon belief that pregnancy should be considered a cate-
gorically high-risk condition in the initial approach to a
patient with possible PE. This is important because
overinvestigation for PE has negative health effects.50,51
The major strengths of this work are the large num-
ber of patients, the lack of evidence of heterogeneity or
publication bias for the RR calculation, and the fact that
the authors had access to patient-level data in the
majority of studies, permitting sensitivity and subgroup
calculations that bolster the assertion that pregnancy
does not confer a high risk of VTE outcome. First, in a
Figure 2. Funnel plot of the RR of VTE outcome for pregnant
patients compared with nonpregnant patients for the 17
included studies. RR = relative risk; VTE = venous thromboem-
bolism.
Table 2
Data From Included Studies
Citation All
Nonpregnant
Patients
Pregnant
Patients
Third
Trimester
VTE+
Total Nonpregnant Pregnant
Third
Trimester
Kline et al.34 934 910 24 3 181 181 2 0
Kline et al.35 1,339 1,278 61 — 77 77 2 —
Kline and Hogg36 178 174 4 3 24 24 0 0
Kline et al.37 2,302 2,231 71 — 108 108 2 —
Roy et al.41 1,529 1,517 12 — 442 441 1 —
Runyon et al.38 1,193 1,188 5 2 45 45 0 0
Nordenholz et al.39 304 299 5 — 22 22 0 —
Turedi et al.48 130 127 3 — 75 75 2 —
Than et al.40 3,224 3,162 62 50 269 269 4 4
Roy et al.42 1,645 1,626 19 — 313 313 0 —
Crichlow et al.30 152 149 3 — 8 8 0 —
Kline et al.43 353 345 8 — 46 46 0 —
Courtney et al.5 7,940 7,792 148 54 561 561 3 0
Dresden et al.46 146 145 1 — 30 30 0 —
Shujaat et al.47 231 228 3 — 48 0 0 —
Adams et al.31 3,500 3,430 70 — 340 338 2 —
Hogg et al.49 239 232 7 5 47 47 0 0
Subtotal (Full-length
papers)
25,339 24,833 506 117 2,636 2,272 18 4
Sonde et al.44* 90 0 90 — 5 0 5 —
Nijkeuter et al.45* 149 0 149 — 6 0 6 —
Total all studies 25,578 24,822 745 117 2,647 2,272 29 4
VTE = venous thromboembolism.
*Abstracts only, included in sensitivity analysis.
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sensitivity analysis from 11 studies, the RR of pregnant
status remained low (I² = 0%, ﬁxed-effects RR of 0.56,
95% CI = 0.34 to 0.93) when compared with nonpreg-
nant patients of childbearing age. For the sensitivity
analysis that examined non-US studies, the RR was sim-
ilar (0.61), but the upper limit of the 95% CI was above
unity (95% CI = 0.27 to 1.39). Sparse data were available
from third trimester patients, resulting in a RR and rela-
tively wide 95% CIs 0.85 (95% CI = 0.40 to 1.77) that
include the possibility that third-trimester pregnancy
increases risk among patients presenting to the ED.
We do not interpret these data to indicate that preg-
nant patients have a lower risk of PE when compared
to healthy nonpregnant patients. Instead, we believe
that our data illustrate that clinicians order testing at a
low test threshold among pregnant patients. The evalua-
tion of a pregnant patient with signs and symptoms of
PE in the emergency setting obligates clinicians to con-
sider a complex mix of information that often causes
decisional conﬂict. Pregnancy clearly represents a popu-
lation risk factor for VTE, but at the same time, most
pregnant patients are relatively healthy compared with
nonpregnant patients undergoing testing for PE. In
their training, clinicians may be taught that PE is the
most, or one of the most, common treatable causes of
maternal death. Expert guidelines and book chapters
clearly state that PE can only be diagnosed or excluded
with reasonable certainty by pulmonary vascular imag-
ing.19,24 Yet, the clinician’s decision of how to test affects
two vulnerable subjects, and excessive testing could
harm the fetus by exposing it to ionizing radiation;
neonatal hypothyroidism remains a possibility because
non–ion-iodinated contrast crosses the placenta.52–54
Radiation from CTPA to the female breast may increase
risk of cancer.55 Exclusion of PE with nonionizing
means, such as decision rules and a D-dimer level, is
confounded by the lack of data in pregnant patients
and that pregnancy naturally elevates the plasma
D-dimer concentration, rendering D-dimer inefﬁcient as
a screening tool by the third trimester because the
D-dimer concentration exceeds the standard threshold
in nearly all women in the third trimester, even with
normal pregnancy.3,4 Within this context of conﬂicting
rationale, our data open the possibility that pregnant
patients could be safely excluded using existing decision
rules coupled with a threshold-adjusted D-dimer level,
or following a protocol whereby bilateral lower extrem-
ity compression ultrasonography is the initial diagnostic
test, as has been suggested by Pahade et al.,56 although
this approach has not been tested.
LIMITATIONS
The most likely factor that might change our ﬁndings
would be data from studies that included pregnant
patients that we missed. We minimized this threat to
validity by using broad search term criteria to locate
studies of ED patients that might have included preg-
nant patients. However, we recognize that unlike a typi-
cal meta-analysis of diagnostic accuracy, which
aggregates data from studies performed to examine a
speciﬁc test, we aggregated supporting data to assess
Figure 3. Relative risk of pregnancy for diagnosis of venous thromboembolism (random effects model).
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(a)
(b)
Figure 4. Frequency of diagnosis of venous thromboembolism in (A) nonpregnant and (B) pregnant patients.
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predictive value of a patient phenotype. Most articles
did not report the breakdown of data required for
meta-analysis, namely the number of nonpregnant and
pregnant patients with and without VTE. To further
minimize the risk of missing data, we e-mailed 56
authors on numerous occasions to ask if they recorded
pregnancy data. Among the 26 authors who responded,
all but three indicated that they either excluded preg-
nancy or could not tell us pregnancy status. For the
three who responded with new data, their published
works had indicated the numbers of pregnant patients
that were included, but did not state their VTE status.30–33
However, in no case did an author inform us that he or
she collected pregnancy data, but reported none of these
data in the resulting article.
CONCLUSIONS
This systematic review and meta-analysis of 25,399
patients found that symptomatic pregnant ED patients
tested for pulmonary embolism had a low outcome rate
of venous thromboembolism and a relative risk for
venous thromboembolism diagnosis that was lower
than that for nonpregnant ED patients, including a sub-
group analysis of patients of childbearing age. These
ﬁndings challenge the common belief that pregnant
patients with symptoms of pulmonary embolism are at
high risk for pulmonary embolism diagnosis.
The authors thank Thomas Emmett, Medical Librarian, for his
assistance with EMBASE.
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